Pub Date : 2026-02-01Epub Date: 2025-11-07DOI: 10.1016/j.ajpath.2025.10.007
César I. Gaspari , Carine Beaupere , Seth Richard , Estanislao Peixoto , Bouchra Lekbaby , Mirko Minini , Branko Dubravcic , Javier Vaquero , Marie Vallette , Ander Arbelaiz , Marion Janona , Corentin Louis , Pauline Le Gall , Cédric Coulouarn , Julieta Marrone , Juan E. Abrahante , Raúl A. Marinelli , Sergio A. Gradilone , Laura Fouassier
Aquaporin-1 (AQP1) is a water channel expressed by cholangiocytes described to modulate cell proliferation and invasion in several cancers. But the role of AQP1 in cholangiocarcinoma (CCA) remains unknown. The aim was to study the function of AQP1 in CCA. AQP1 expression was evaluated in 39 intrahepatic CCA (iCCA) specimens from transcriptomic data. AQP1-knockout in HuCCT1 iCCA cells was achieved by clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9). Next-generation sequencing (RNA sequencing) was performed to study the consequences of AQP1 inhibition on cell phenotype. Epithelial-mesenchymal transition (EMT), cell migration and proliferation, and signaling pathways were evaluated by live-cell imaging system, quantitative RT-PCR, Western blot, and immunostaining. In vivo experiments were performed using a xenograft CCA model. In human iCCA, low AQP1 expression correlated with reduced overall survival. In vivo, CCA cells depleted for AQP1 displayed a higher tumorigenic potential than control cells. In vitro, RNA-sequencing analysis of AQP1-depleted CCA cells showed signatures of tumor progression, including EMT. Indeed, AQP1-depleted cells showed a cell dispersion phenotype, loss of the junction protein E-cadherin, and higher expression of vimentin and zinc finger E-box binding homeobox 1 (ZEB1), along with stemness traits. Functionally, loss of AQP1 is associated with increased cell migration and proliferation. Moreover, an activation of the insulin-like growth factor 2/insulin-like growth factor 1 receptor/insulin receptor pathway was found in AQP1-depleted CCA cells. The data suggest that AQP1 acts as a tumor suppressor in iCCA.
{"title":"Loss of Aquaporin-1 in Tumor Cells Fosters Intrahepatic Cholangiocarcinoma Progression","authors":"César I. Gaspari , Carine Beaupere , Seth Richard , Estanislao Peixoto , Bouchra Lekbaby , Mirko Minini , Branko Dubravcic , Javier Vaquero , Marie Vallette , Ander Arbelaiz , Marion Janona , Corentin Louis , Pauline Le Gall , Cédric Coulouarn , Julieta Marrone , Juan E. Abrahante , Raúl A. Marinelli , Sergio A. Gradilone , Laura Fouassier","doi":"10.1016/j.ajpath.2025.10.007","DOIUrl":"10.1016/j.ajpath.2025.10.007","url":null,"abstract":"<div><div>Aquaporin-1 (AQP1) is a water channel expressed by cholangiocytes described to modulate cell proliferation and invasion in several cancers. But the role of AQP1 in cholangiocarcinoma (CCA) remains unknown. The aim was to study the function of AQP1 in CCA. AQP1 expression was evaluated in 39 intrahepatic CCA (iCCA) specimens from transcriptomic data. AQP1-knockout in HuCCT1 iCCA cells was achieved by clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9). Next-generation sequencing (RNA sequencing) was performed to study the consequences of AQP1 inhibition on cell phenotype. Epithelial-mesenchymal transition (EMT), cell migration and proliferation, and signaling pathways were evaluated by live-cell imaging system, quantitative RT-PCR, Western blot, and immunostaining. <em>In vivo</em> experiments were performed using a xenograft CCA model. In human iCCA, low AQP1 expression correlated with reduced overall survival. <em>In vivo</em>, CCA cells depleted for AQP1 displayed a higher tumorigenic potential than control cells. <em>In vitro,</em> RNA-sequencing analysis of AQP1-depleted CCA cells showed signatures of tumor progression, including EMT. Indeed, AQP1-depleted cells showed a cell dispersion phenotype, loss of the junction protein E-cadherin, and higher expression of vimentin and zinc finger E-box binding homeobox 1 (ZEB1), along with stemness traits. Functionally, loss of AQP1 is associated with increased cell migration and proliferation. Moreover, an activation of the insulin-like growth factor 2/insulin-like growth factor 1 receptor/insulin receptor pathway was found in AQP1-depleted CCA cells. The data suggest that AQP1 acts as a tumor suppressor in iCCA.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 428-444"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-06DOI: 10.1016/j.ajpath.2025.10.009
Taymaz Akan , Sait Alp , Richa Aishwarya , Diensn G. Xing , Destyn Dicharry , Md. Shenuarin Bhuiyan , Mohammad Alfrad Nobel Bhuiyan
Analyzing skeletal muscle pathology from histological images is labor intensive (requiring manual cell counting, segmentation, and thresholding), time consuming, and prone to inter- and intrauser variability, influencing the accuracy and consistency of diagnoses. To address these difficulties, PathViT, a transformer-based deep-learning model, was designed to automatically distinguish between healthy and diseased muscle fibers, with the aims of reducing human intervention, minimizing subjectivity and variability, and significantly decreasing analysis time compared to conventional manual methods. Skeletal muscle pathology is characterized by changes in myofiber cross-sectional area, increased central nuclei, and structural disruptions in sarcomeres. To investigate these changes in myofiber size, wheat germ agglutinin staining and digital histopathology of skeletal muscle (quadriceps, gastrocnemius, tibialis anterior, extensor digitorum longus, and soleus) was utilized to classify diseased tissue [amyotrophic lateral sclerosis (SOD1∗G93A) and type 1 diabetes (Akita)] versus nondiseased controls. The performance of PathViT in distinguishing diseased versus nondiseased muscle fibers was compared with that of state-of-the-art deep-learning models. PathViT classified healthy and diseased muscle fibers with 96% accuracy, outperforming the other models. This approach enhanced scalability and diagnostic accuracy and decreased variability, making PathViT a potentially powerful biomedical research and clinical tool.
{"title":"PathViT Model for Automated Disease Classification from Skeletal Muscle Histopathology","authors":"Taymaz Akan , Sait Alp , Richa Aishwarya , Diensn G. Xing , Destyn Dicharry , Md. Shenuarin Bhuiyan , Mohammad Alfrad Nobel Bhuiyan","doi":"10.1016/j.ajpath.2025.10.009","DOIUrl":"10.1016/j.ajpath.2025.10.009","url":null,"abstract":"<div><div>Analyzing skeletal muscle pathology from histological images is labor intensive (requiring manual cell counting, segmentation, and thresholding), time consuming, and prone to inter- and intrauser variability, influencing the accuracy and consistency of diagnoses. To address these difficulties, PathViT, a transformer-based deep-learning model, was designed to automatically distinguish between healthy and diseased muscle fibers, with the aims of reducing human intervention, minimizing subjectivity and variability, and significantly decreasing analysis time compared to conventional manual methods. Skeletal muscle pathology is characterized by changes in myofiber cross-sectional area, increased central nuclei, and structural disruptions in sarcomeres. To investigate these changes in myofiber size, wheat germ agglutinin staining and digital histopathology of skeletal muscle (quadriceps, gastrocnemius, tibialis anterior, extensor digitorum longus, and soleus) was utilized to classify diseased tissue [amyotrophic lateral sclerosis (<em>SOD1∗G93A</em>) and type 1 diabetes (Akita)] versus nondiseased controls. The performance of PathViT in distinguishing diseased versus nondiseased muscle fibers was compared with that of state-of-the-art deep-learning models. PathViT classified healthy and diseased muscle fibers with 96% accuracy, outperforming the other models. This approach enhanced scalability and diagnostic accuracy and decreased variability, making PathViT a potentially powerful biomedical research and clinical tool.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 505-514"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-20DOI: 10.1016/j.ajpath.2025.10.008
Hannah R. Hrncir , Brianna Goodloe , Sergei Bombin , Siyang J. Sun , Zelin Zhang , Anant Madabhushi , Adam D. Gracz
Intrahepatic bile ducts (IHBDs) form a complex hierarchical network essential for liver function. The remodeling and expansion of this network during ductular reaction (DR) are hallmarks of liver disease that can be key indicators of disease severity. Conventional histology fails to capture the full extent of IHBD structural changes after injury due to the complex three-dimensional (3D) organization of the IHBD network that limits understanding of DR, especially in human tissue. A major barrier to leveraging 3D imaging as a diagnostic tool is the absence of standardized pipelines for IHBD imaging and analysis. This work establishes a robust 3D IHBD imaging and analysis workflow, applying it to both mouse and human liver tissues. This pipeline enables quantification of tissue and individual duct (“segment”) level features and identifies features of invasive and noninvasive DR. In mouse models, we uncover regional phenotypes, including IHBD diverticula-like structures after duct blockage and the formation of anastomosed clusters after hepatocellular injury. Finally, this 3D imaging and analysis workflow is applied to quantify IHBD networks in human liver tissue. This work deepens our understanding of IHBD architecture in homeostasis and injury, laying the groundwork for advanced phenotyping of IHBD morphologies in mice and humans with relevance to next-generation experimental and diagnostic approaches to liver disease.
{"title":"Quantitative 3D Imaging of Mouse and Human Intrahepatic Bile Ducts in Homeostasis and Liver Injury","authors":"Hannah R. Hrncir , Brianna Goodloe , Sergei Bombin , Siyang J. Sun , Zelin Zhang , Anant Madabhushi , Adam D. Gracz","doi":"10.1016/j.ajpath.2025.10.008","DOIUrl":"10.1016/j.ajpath.2025.10.008","url":null,"abstract":"<div><div>Intrahepatic bile ducts (IHBDs) form a complex hierarchical network essential for liver function. The remodeling and expansion of this network during ductular reaction (DR) are hallmarks of liver disease that can be key indicators of disease severity. Conventional histology fails to capture the full extent of IHBD structural changes after injury due to the complex three-dimensional (3D) organization of the IHBD network that limits understanding of DR, especially in human tissue. A major barrier to leveraging 3D imaging as a diagnostic tool is the absence of standardized pipelines for IHBD imaging and analysis. This work establishes a robust 3D IHBD imaging and analysis workflow, applying it to both mouse and human liver tissues. This pipeline enables quantification of tissue and individual duct (“segment”) level features and identifies features of invasive and noninvasive DR. In mouse models, we uncover regional phenotypes, including IHBD diverticula-like structures after duct blockage and the formation of anastomosed clusters after hepatocellular injury. Finally, this 3D imaging and analysis workflow is applied to quantify IHBD networks in human liver tissue. This work deepens our understanding of IHBD architecture in homeostasis and injury, laying the groundwork for advanced phenotyping of IHBD morphologies in mice and humans with relevance to next-generation experimental and diagnostic approaches to liver disease.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 445-459"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-09-30DOI: 10.1016/j.ajpath.2025.09.006
Devy Deliyanti, Varaporn Suphapimol, Phoebe Ang, Abhirup Jayasimhan, Jennifer L. Wilkinson-Berka
Diabetic retinopathy, a leading cause of blindness, features damage to the retinal vasculature, where T-cell–mediated inflammation is increasingly recognized as an important contributor. Retinoic acid receptor-related orphan receptor gamma (RORγ) plays a key role in regulating the balance between anti-inflammatory regulatory T cells (Tregs) expressing the transcription factor Foxp3 and proinflammatory Th17 cells. It was hypothesized that inhibiting RORγ with SR2211, targeting both RORγ and its isoform RORγt, increases Tregs and reduces Th17 cells, resulting in reduced inflammation and vasculopathy in a streptozotocin-induced model of diabetic retinopathy. Mice expressing Foxp3 as a red fluorescent protein were treated with SR2211 for 26 weeks of diabetes, and comparisons made to diabetic mice administered vehicle and non-diabetic control mice. In blood and lymphoid tissues of diabetic mice, treatment with SR2211 restored the number of Tregs and reduced Th17 cells to the levels of diabetic mice + vehicle. In the retina of diabetic mice, treatment with SR2211 increased Tregs and reduced the activation of microglia cells, the expression of proinflammatory factors including IL-17A, IL-6 and tumor necrosis factor, vascular leakage, vascular endothelial growth factor, and acellular capillaries, compared with diabetic mice + vehicle. These findings indicate the ability of RORγ/RORγt inhibition to modulate specific T-cell responses and suppress microglia activation to reduce inflammation and vascular damage in diabetic retinopathy.
{"title":"Targeting RORγ to Boost Regulatory T cells and Ameliorate Diabetic Retinopathy in Mice","authors":"Devy Deliyanti, Varaporn Suphapimol, Phoebe Ang, Abhirup Jayasimhan, Jennifer L. Wilkinson-Berka","doi":"10.1016/j.ajpath.2025.09.006","DOIUrl":"10.1016/j.ajpath.2025.09.006","url":null,"abstract":"<div><div>Diabetic retinopathy, a leading cause of blindness, features damage to the retinal vasculature, where T-cell–mediated inflammation is increasingly recognized as an important contributor. Retinoic acid receptor-related orphan receptor gamma (RORγ) plays a key role in regulating the balance between anti-inflammatory regulatory T cells (Tregs) expressing the transcription factor Foxp3 and proinflammatory Th17 cells. It was hypothesized that inhibiting RORγ with SR2211, targeting both RORγ and its isoform RORγt, increases Tregs and reduces Th17 cells, resulting in reduced inflammation and vasculopathy in a streptozotocin-induced model of diabetic retinopathy. Mice expressing Foxp3 as a red fluorescent protein were treated with SR2211 for 26 weeks of diabetes, and comparisons made to diabetic mice administered vehicle and non-diabetic control mice. In blood and lymphoid tissues of diabetic mice, treatment with SR2211 restored the number of Tregs and reduced Th17 cells to the levels of diabetic mice + vehicle. In the retina of diabetic mice, treatment with SR2211 increased Tregs and reduced the activation of microglia cells, the expression of proinflammatory factors including IL-17A, IL-6 and tumor necrosis factor, vascular leakage, vascular endothelial growth factor, and acellular capillaries, compared with diabetic mice + vehicle. These findings indicate the ability of RORγ/RORγt inhibition to modulate specific T-cell responses and suppress microglia activation to reduce inflammation and vascular damage in diabetic retinopathy.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 562-574"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145211330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.ajpath.2026.01.003
Christina A Nelson, J Daniel Obray, Charles R Roll, Pacen E Williams, Kathryn J Smith, William T Harris, Caylor W Hafen, Matthew D Burris, Kim H Manwaring, Daniel N Adams, K Scott Weber, Sandra Hope, Ulrike H Mitchell, Jordan T Yorgason, Scott C Steffensen
Having the ability to objectively index dopamine (DA) levels in the brain with a peripheral biomarker of brain DA would enable the objective monitoring of the progression of Parkinson disease (PD) and other DA-dependent disorders. This study investigates this potential biomarker using a DA-depletion approach, the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin model and subjects with PD, which are well-known models of DA depletion in the midbrain of rodents and humans, respectively. MPTP-induced DA depletion in the substantia nigra compacta resulted in a significant decrease in DA and norepinephrine levels in the blood. The proportion of dopamine D2 receptor (D2R)-expressing leukocytes progressively decreased (specifically B and T cells) during the DA depletion. Subjects with PD displayed significantly decreased D2R expression in B and T cells, and increased levels in epinephrine, DA, norepinephrine, and levodopa, compared with control subjects. A significant negative correlation was found between blood levodopa and D2R expression in classical monocytes, which correlated mildly with blood DA levels. The modulation of peripheral D2Rs in PD and MPTP seen in this study demonstrates that substantia nigra compacta dopamine depletion in humans and rodents does manifest in the periphery. Although this study did not provide a clear narrative of how nigral and peripheral dopamine systems mirror each other, the results give evidence that peripheral D2Rs may be both biomarkers and important substrates for treatment of dopamine-dependent disorders.
{"title":"Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease.","authors":"Christina A Nelson, J Daniel Obray, Charles R Roll, Pacen E Williams, Kathryn J Smith, William T Harris, Caylor W Hafen, Matthew D Burris, Kim H Manwaring, Daniel N Adams, K Scott Weber, Sandra Hope, Ulrike H Mitchell, Jordan T Yorgason, Scott C Steffensen","doi":"10.1016/j.ajpath.2026.01.003","DOIUrl":"10.1016/j.ajpath.2026.01.003","url":null,"abstract":"<p><p>Having the ability to objectively index dopamine (DA) levels in the brain with a peripheral biomarker of brain DA would enable the objective monitoring of the progression of Parkinson disease (PD) and other DA-dependent disorders. This study investigates this potential biomarker using a DA-depletion approach, the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin model and subjects with PD, which are well-known models of DA depletion in the midbrain of rodents and humans, respectively. MPTP-induced DA depletion in the substantia nigra compacta resulted in a significant decrease in DA and norepinephrine levels in the blood. The proportion of dopamine D2 receptor (D2R)-expressing leukocytes progressively decreased (specifically B and T cells) during the DA depletion. Subjects with PD displayed significantly decreased D2R expression in B and T cells, and increased levels in epinephrine, DA, norepinephrine, and levodopa, compared with control subjects. A significant negative correlation was found between blood levodopa and D2R expression in classical monocytes, which correlated mildly with blood DA levels. The modulation of peripheral D2Rs in PD and MPTP seen in this study demonstrates that substantia nigra compacta dopamine depletion in humans and rodents does manifest in the periphery. Although this study did not provide a clear narrative of how nigral and peripheral dopamine systems mirror each other, the results give evidence that peripheral D2Rs may be both biomarkers and important substrates for treatment of dopamine-dependent disorders.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-09-30DOI: 10.1016/j.ajpath.2025.09.010
Siddhi Jain , Ranjan Mukherjee , Gillian Williams , Jia-Jun Liu , Lanuza A.P. Faccioli , Zhiping Hu , Rodrigo M. Florentino , George K. Michalopoulos , Alejandro Soto-Gutierrez , Silvia Liu , Joseph Locker , Bharat Bhushan
Despite the well-known role of MET in liver regeneration after partial hepatectomy, its role in the clinically relevant acetaminophen (APAP)-induced liver injury (AILI) model remains unexplored. AILI markedly differs from partial hepatectomy because it is associated with massive liver necrosis. This study aims to delineate the role of MET specifically in AILI. Hepatocyte-specific MET knockout (MET KO) mice were administered a toxic dose of APAP and assessed for liver injury/regeneration parameters. MET deletion strikingly exacerbated the initial hepatotoxicity and consequentially impaired the compensatory proliferative response, culminating in significant mortality. Mechanistically, MET deletion enhanced c-Jun N-terminal kinase (JNK) activation and its mitochondrial translocation, resulting in excessive mitochondrial oxidative damage, releasing apoptosis-inducing factor into cytosol. Excess JNK activation was attributed to reduced inhibitory activity of AKT on JNK in the absence of MET signaling. Pharmacologic activation of AKT reduced JNK activation and hepatotoxicity in MET KO mice. RNA-sequencing/immunoblotting not only showed repression of proliferative/survival signaling but also activation of cell death/senescence pathways along with an impaired unfolded protein response in MET KO mice. Analysis of published single-nucleus RNA-sequencing data showed that proliferation in livers from patients with APAP-induced acute liver failure was associated with strong activation of hepatocyte growth factor/MET signaling in hepatocytes, with spatial transcriptomics showing striking induction of hepatocyte growth factor surrounding the necrotic zones. Interestingly, 35% of the genes altered in human acute liver failure were regulated by MET in the mouse AILI model. The current study shows that MET is crucial for restraining hepatotoxicity after APAP overdose via inhibition of the mitochondrial cell death signaling pathway.
{"title":"Hepatocyte-Specific MET Deletion Exacerbates Acetaminophen-Induced Hepatotoxicity in Mice","authors":"Siddhi Jain , Ranjan Mukherjee , Gillian Williams , Jia-Jun Liu , Lanuza A.P. Faccioli , Zhiping Hu , Rodrigo M. Florentino , George K. Michalopoulos , Alejandro Soto-Gutierrez , Silvia Liu , Joseph Locker , Bharat Bhushan","doi":"10.1016/j.ajpath.2025.09.010","DOIUrl":"10.1016/j.ajpath.2025.09.010","url":null,"abstract":"<div><div>Despite the well-known role of MET in liver regeneration after partial hepatectomy, its role in the clinically relevant acetaminophen (APAP)-induced liver injury (AILI) model remains unexplored. AILI markedly differs from partial hepatectomy because it is associated with massive liver necrosis. This study aims to delineate the role of MET specifically in AILI. Hepatocyte-specific MET knockout (MET KO) mice were administered a toxic dose of APAP and assessed for liver injury/regeneration parameters. MET deletion strikingly exacerbated the initial hepatotoxicity and consequentially impaired the compensatory proliferative response, culminating in significant mortality. Mechanistically, MET deletion enhanced c-Jun N-terminal kinase (JNK) activation and its mitochondrial translocation, resulting in excessive mitochondrial oxidative damage, releasing apoptosis-inducing factor into cytosol. Excess JNK activation was attributed to reduced inhibitory activity of AKT on JNK in the absence of MET signaling. Pharmacologic activation of AKT reduced JNK activation and hepatotoxicity in MET KO mice. RNA-sequencing/immunoblotting not only showed repression of proliferative/survival signaling but also activation of cell death/senescence pathways along with an impaired unfolded protein response in MET KO mice. Analysis of published single-nucleus RNA-sequencing data showed that proliferation in livers from patients with APAP-induced acute liver failure was associated with strong activation of hepatocyte growth factor/MET signaling in hepatocytes, with spatial transcriptomics showing striking induction of hepatocyte growth factor surrounding the necrotic zones. Interestingly, 35% of the genes altered in human acute liver failure were regulated by MET in the mouse AILI model. The current study shows that MET is crucial for restraining hepatotoxicity after APAP overdose via inhibition of the mitochondrial cell death signaling pathway.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 388-406"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145211340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-20DOI: 10.1016/j.ajpath.2025.09.009
Blandine Baffert , Kevin Schneider , Audrey Wetzel , Ludivine Dal Zuffo , Cécile Chagué , Eléa Mitifiot , Francis Bonnefoy , Alicja Kuzniewska , Philippe Saas , Jamal Bamoulid , Gwenael Rolin , Sylvain Perruche , Sanja Arandjelovic
Macrophages are critical regulators of inflammation with an essential role in maintaining and re-establishing homeostasis after inflammatory insults. However, excessive macrophage activation could promote fibrosis, highlighting their potential as a therapeutic target in chronic inflammatory diseases. Two preclinical models of systemic sclerosis, bleomycin-induced systemic scleroderma and sclerodermatous graft-versus-host disease, were used to analyze the role of macrophages in the establishment of fibrosis. In both models, macrophage numbers increase in the skin and lungs, in association with elevated collagen content and correlating with fibrosis development. These macrophages had a Ly6clowCD206+MerTk+ phenotype, suggesting a profibrotic role during disease progression. Using macrophage depletion and differentiation blocking approaches, this work shows that reduced macrophage accumulation effectively prevented bleomycin-induced fibrosis development. Direct profibrotic activity of bleomycin-exposed macrophages was revealed by s.c. macrophage injections in naïve mice, which was sufficient to induce systemic fibrosis. Finally, bleomycin-treated primary mouse and human macrophages display reduced clearance of apoptotic cells and secrete factors that promote fibroblast activation and collagen production. Metabolic and mitochondrial dysfunction, changes in receptor shedding, and cytoskeletal reorganization in bleomycin-treated macrophages further contribute to their impaired efferocytosis and enhanced profibrotic activity. Collectively, this work identifies macrophages as critical promoters of tissue fibrosis and suggests that inhibition of macrophage activation represents a new potent therapeutic avenue in efforts to reverse fibrosis associated with chronic inflammation.
{"title":"Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model","authors":"Blandine Baffert , Kevin Schneider , Audrey Wetzel , Ludivine Dal Zuffo , Cécile Chagué , Eléa Mitifiot , Francis Bonnefoy , Alicja Kuzniewska , Philippe Saas , Jamal Bamoulid , Gwenael Rolin , Sylvain Perruche , Sanja Arandjelovic","doi":"10.1016/j.ajpath.2025.09.009","DOIUrl":"10.1016/j.ajpath.2025.09.009","url":null,"abstract":"<div><div>Macrophages are critical regulators of inflammation with an essential role in maintaining and re-establishing homeostasis after inflammatory insults. However, excessive macrophage activation could promote fibrosis, highlighting their potential as a therapeutic target in chronic inflammatory diseases. Two preclinical models of systemic sclerosis, bleomycin-induced systemic scleroderma and sclerodermatous graft-<em>versus</em>-host disease, were used to analyze the role of macrophages in the establishment of fibrosis. In both models, macrophage numbers increase in the skin and lungs, in association with elevated collagen content and correlating with fibrosis development. These macrophages had a Ly6c<sup>low</sup>CD206<sup>+</sup>MerTk<sup>+</sup> phenotype, suggesting a profibrotic role during disease progression. Using macrophage depletion and differentiation blocking approaches, this work shows that reduced macrophage accumulation effectively prevented bleomycin-induced fibrosis development. Direct profibrotic activity of bleomycin-exposed macrophages was revealed by s.c. macrophage injections in naïve mice, which was sufficient to induce systemic fibrosis. Finally, bleomycin-treated primary mouse and human macrophages display reduced clearance of apoptotic cells and secrete factors that promote fibroblast activation and collagen production. Metabolic and mitochondrial dysfunction, changes in receptor shedding, and cytoskeletal reorganization in bleomycin-treated macrophages further contribute to their impaired efferocytosis and enhanced profibrotic activity. Collectively, this work identifies macrophages as critical promoters of tissue fibrosis and suggests that inhibition of macrophage activation represents a new potent therapeutic avenue in efforts to reverse fibrosis associated with chronic inflammation.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 460-478"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-20DOI: 10.1016/j.ajpath.2025.10.013
Madiha Zahra Syeda , Emily S.H. Yeung , Lisa Y.Q. Hong , Suzanne L. Advani , Youan Liu , Laurette Geldenhuys , Ferhan S. Siddiqi , Veera Ganesh Yerra , Sri Nagarjun Batchu , Andrew Advani
Recent years have seen substantial scientific excitement in the role that the double-stranded DNA sensor and mediator of inflammation, stimulator of interferon genes (STING), plays in kidney disease. However, the STING pathway is not the sole regulator of inflammation, and STING has roles other than in inflammation. Here, elevated STING levels were observed in both human and mouse kidney disease, and the effects of STING deletion from kidney tubule cells, myeloid cells, and globally in experimental kidney disease were examined. Inflammatory gene up-regulation in tubule cells, induced by double-stranded DNA, was attenuated (but not negated) by STING knockout. Either myeloid or global knockout of STING marginally diminished fibroinflammatory gene up-regulation in mice with kidney injury caused by unilateral ureteral obstruction, whereas tubule cell knockout of STING unexpectedly augmented inflammatory gene up-regulation. Global knockout of STING similarly worsened diabetic kidney disease, likely due to heightened hyperglycemia. Antagonism of STING attenuated autophagy induction in human tubule cells, but not in human glomerular endothelial cells or podocytes. These findings serve as a counterweight to the enthusiasm that has recently emerged as to the roles of STING-mediated signaling in kidney disease. The actions of STING extend beyond its role in inflammation, and they are cell type dependent. STING may be a fine-tuner, but it is unlikely to be a prime mover, of inflammation in kidney disease.
{"title":"Stimulator of Interferon Genes Is a Fine-Tuner, but Not a Prime Mover, of Kidney Inflammation","authors":"Madiha Zahra Syeda , Emily S.H. Yeung , Lisa Y.Q. Hong , Suzanne L. Advani , Youan Liu , Laurette Geldenhuys , Ferhan S. Siddiqi , Veera Ganesh Yerra , Sri Nagarjun Batchu , Andrew Advani","doi":"10.1016/j.ajpath.2025.10.013","DOIUrl":"10.1016/j.ajpath.2025.10.013","url":null,"abstract":"<div><div>Recent years have seen substantial scientific excitement in the role that the double-stranded DNA sensor and mediator of inflammation, stimulator of interferon genes (STING), plays in kidney disease. However, the STING pathway is not the sole regulator of inflammation, and STING has roles other than in inflammation. Here, elevated STING levels were observed in both human and mouse kidney disease, and the effects of STING deletion from kidney tubule cells, myeloid cells, and globally in experimental kidney disease were examined. Inflammatory gene up-regulation in tubule cells, induced by double-stranded DNA, was attenuated (but not negated) by STING knockout. Either myeloid or global knockout of STING marginally diminished fibroinflammatory gene up-regulation in mice with kidney injury caused by unilateral ureteral obstruction, whereas tubule cell knockout of STING unexpectedly augmented inflammatory gene up-regulation. Global knockout of STING similarly worsened diabetic kidney disease, likely due to heightened hyperglycemia. Antagonism of STING attenuated autophagy induction in human tubule cells, but not in human glomerular endothelial cells or podocytes. These findings serve as a counterweight to the enthusiasm that has recently emerged as to the roles of STING-mediated signaling in kidney disease. The actions of STING extend beyond its role in inflammation, and they are cell type dependent. STING may be a fine-tuner, but it is unlikely to be a prime mover, of inflammation in kidney disease.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 515-531"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-06DOI: 10.1016/j.ajpath.2025.10.006
Arpan Banerjee , Mohammad Anjum Shaik , Christine Tilstra-Smith , Nileyma Castro , Jelissa Reynoso-Garcia , Michael E. Zuber , Audrey M. Bernstein
Persistent corneal epithelial defect is a condition in which the corneal epithelium fails to heal properly after injury, resulting in vision loss. Previous studies demonstrate that the deubiquitinase, ubiquitin-specific peptidase 10 (USP10), is a key regulator of wound healing and scarring in the cornea. Here, a highly modified in vivo self-delivering siRNA (sdRNA) targeting USP10 in a mouse model of persistent corneal epithelial defect was used. In this model, the corneal epithelium is scraped from the basement membrane and, although the wound initially closes, the epithelium re-opens at day 28, thereby modeling a persistent corneal defect. These studies revealed that one dose of USP10-targeting sdRNA after wounding prevented re-opening of the wound at day 28. Optical coherence tomography images, hematoxylin and eosin staining, and immunohistochemistry demonstrated improved corneal morphology and normal epithelial stratification of the regrown epithelium, with re-establishment of hemidesmosomes and reduced scarring and inflammation (CD45+ cells). Correspondingly, RNA sequencing of the regenerated corneal epithelium revealed that USP10 knockdown altered gene expression and pathways controlling tissue repair. Specifically, cell proliferation pathways were enhanced, whereas extracellular matrix, integrin, and immune cell signatures that lead to scar formation were reduced. The results demonstrate that a one-time application of in vivo sdRNA targeting USP10 is a novel method to prevent epithelial wound re-opening and subsequent scarring and inflammation and may be useful to promote regenerative healing in other tissues.
{"title":"Silencing Ubiquitin-Specific Peptidase 10 Alleviates Persistent Corneal Epithelial Defect in Mice","authors":"Arpan Banerjee , Mohammad Anjum Shaik , Christine Tilstra-Smith , Nileyma Castro , Jelissa Reynoso-Garcia , Michael E. Zuber , Audrey M. Bernstein","doi":"10.1016/j.ajpath.2025.10.006","DOIUrl":"10.1016/j.ajpath.2025.10.006","url":null,"abstract":"<div><div>Persistent corneal epithelial defect is a condition in which the corneal epithelium fails to heal properly after injury, resulting in vision loss. Previous studies demonstrate that the deubiquitinase, ubiquitin-specific peptidase 10 (USP10), is a key regulator of wound healing and scarring in the cornea. Here, a highly modified <em>in vivo</em> self-delivering siRNA (sdRNA) targeting USP10 in a mouse model of persistent corneal epithelial defect was used. In this model, the corneal epithelium is scraped from the basement membrane and, although the wound initially closes, the epithelium re-opens at day 28, thereby modeling a persistent corneal defect. These studies revealed that one dose of USP10-targeting sdRNA after wounding prevented re-opening of the wound at day 28. Optical coherence tomography images, hematoxylin and eosin staining, and immunohistochemistry demonstrated improved corneal morphology and normal epithelial stratification of the regrown epithelium, with re-establishment of hemidesmosomes and reduced scarring and inflammation (CD45<sup>+</sup> cells). Correspondingly, RNA sequencing of the regenerated corneal epithelium revealed that USP10 knockdown altered gene expression and pathways controlling tissue repair. Specifically, cell proliferation pathways were enhanced, whereas extracellular matrix, integrin, and immune cell signatures that lead to scar formation were reduced. The results demonstrate that a one-time application of <em>in vivo</em> sdRNA targeting USP10 is a novel method to prevent epithelial wound re-opening and subsequent scarring and inflammation and may be useful to promote regenerative healing in other tissues.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 575-597"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-16DOI: 10.1016/j.ajpath.2025.09.015
Amanda Caceres , Noreene M. Shibata , Christian D. Davalos-Gutierrez , Gaurav V. Sarode , Hisham Hussan , Margarida Bettencourt , Adriana Fontes , Hans Zischka , Svetlana Lutsenko , Marie C. Heffern , Valentina Medici
The clinical manifestations of Wilson disease (WD) are related to copper accumulation in the liver and brain, but little is known about the role of other organs expressing the ATP7B copper transporter on metabolic and ultrastructural changes characterizing WD. To examine the consequences of intestinal Atp7b inactivation in the absence of hepatic copper accumulation, a new mouse model (Atp7bΔIEC) characterized by enterocyte-specific Atp7b inactivation was generated. Atp7bΔIEC mice were compared with wild-type mice with the same genetic background (iWT). The Atp7b global knockout (Atp7b–/–) model of WD on a C57Bl/6 background was previously generated and compared with its respective wild type (WT). Hepatic copper, lipid metabolism, liver and intestine histology, and electron microscopy were assessed over time up to 30 weeks of age. Although there was no evidence of intestine copper accumulation in Atp7bΔIEC mice, transcriptome analysis in Atp7bΔIEC mice revealed changes in genes involved in AMP-activated protein kinase signaling, fatty acid metabolism, and cell cycle both with partial overlap between the intestinal epithelial cells and the liver. Mitochondrial and other ultrastructural changes were observed in the intestinal epithelial cells of both Atp7b–/– and Atp7bΔIEC mice. Intestine-specific Atp7b deficit affects systemic metabolic pathways and intestine morphology, and hepatic metabolic perturbations are associated with intestinal dysfunction, independently from hepatic copper accumulation, providing evidence that the WD phenotype is at least partially influenced by organ-specific ATP7B variants.
{"title":"Inactivation of Atp7b Copper Transporter in Intestinal Epithelial Cells Is Associated with Altered Lipid Processing and Cell Growth Machinery Independent from Hepatic Copper Accumulation and Severity of Liver Histology","authors":"Amanda Caceres , Noreene M. Shibata , Christian D. Davalos-Gutierrez , Gaurav V. Sarode , Hisham Hussan , Margarida Bettencourt , Adriana Fontes , Hans Zischka , Svetlana Lutsenko , Marie C. Heffern , Valentina Medici","doi":"10.1016/j.ajpath.2025.09.015","DOIUrl":"10.1016/j.ajpath.2025.09.015","url":null,"abstract":"<div><div>The clinical manifestations of Wilson disease (WD) are related to copper accumulation in the liver and brain, but little is known about the role of other organs expressing the ATP7B copper transporter on metabolic and ultrastructural changes characterizing WD. To examine the consequences of intestinal <em>Atp7b</em> inactivation in the absence of hepatic copper accumulation, a new mouse model (<em>Atp7b</em><sup>ΔIEC</sup>) characterized by enterocyte-specific <em>Atp7b</em> inactivation was generated. <em>Atp7b</em><sup>ΔIEC</sup> mice were compared with wild-type mice with the same genetic background (iWT). The <em>Atp7b</em> global knockout (<em>Atp7b</em><sup>–/–</sup>) model of WD on a C57Bl/6 background was previously generated and compared with its respective wild type (WT). Hepatic copper, lipid metabolism, liver and intestine histology, and electron microscopy were assessed over time up to 30 weeks of age. Although there was no evidence of intestine copper accumulation in <em>Atp7b</em><sup>ΔIEC</sup> mice, transcriptome analysis in <em>Atp7b</em><sup>ΔIEC</sup> mice revealed changes in genes involved in AMP-activated protein kinase signaling, fatty acid metabolism, and cell cycle both with partial overlap between the intestinal epithelial cells and the liver. Mitochondrial and other ultrastructural changes were observed in the intestinal epithelial cells of both <em>Atp7b</em><sup>–/–</sup> and <em>Atp7b</em><sup>ΔIEC</sup> mice. Intestine-specific <em>Atp7b</em> deficit affects systemic metabolic pathways and intestine morphology, and hepatic metabolic perturbations are associated with intestinal dysfunction, independently from hepatic copper accumulation, providing evidence that the WD phenotype is at least partially influenced by organ-specific ATP7B variants.</div></div>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":"196 2","pages":"Pages 407-427"},"PeriodicalIF":3.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}